{
    "organizations": [],
    "uuid": "6228e836ed8bdcfd32011d56c1a856c04c419b03",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-geneuro-receives-orphan-drug-desig/brief-geneuro-receives-orphan-drug-designation-from-the-us-fda-for-gnbac1-in-chronic-inflammatory-demyelinating-polyneuropathy-idUSASM000JMZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Geneuro Receives Orphan Drug Designation From The Us FDA For Gnbac1 In Chronic Inflammatory Demyelinating Polyneuropathy (Cidp)",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Geneuro Sa:\n* GENEURO RECEIVES ORPHAN DRUG DESIGNATION FROM THE US FDA FOR GNBAC1 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)\n* FORTHCOMING DISCUSSIONS EXPECTED WITH FDA FOR DESIGN OF A PROOF-OF-CONCEPT PHASE 2 CLINICAL STUDY Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-23T01:37:00.000+02:00",
    "crawled": "2018-02-23T15:46:57.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "geneuro",
        "sa",
        "geneuro",
        "receives",
        "orphan",
        "drug",
        "designation",
        "u",
        "fda",
        "gnbac1",
        "chronic",
        "inflammatory",
        "demyelinating",
        "polyneuropathy",
        "cidp",
        "forthcoming",
        "discussion",
        "expected",
        "fda",
        "design",
        "phase",
        "clinical",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}